Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.

[1]  A. Siegelaub,et al.  Cigarettes, alcohol, coffee and peptic ulcer. , 1974, The New England journal of medicine.

[2]  W. Chey,et al.  Smoking and duodenal ulcer. , 1978, Gastroenterology.

[3]  D. Piper,et al.  Analgesic ingestion and chronic peptic ulcer. , 1981, Gastroenterology.

[4]  J. Kurata,et al.  Racial differences in peptic ulcer disease: fact or myth? , 1982, Gastroenterology.

[5]  The influence of sex, race and dialect on peptic ulcer and non-ulcer dyspepsia in Singapore. , 1983, Annals of the Academy of Medicine, Singapore.

[6]  K. Ohe.  [Duodenal ulcer and drug therapy]. , 1984, Nihon rinsho. Japanese journal of clinical medicine.

[7]  K. Byth,et al.  Smoking, alcohol, analgesics, and chronic duodenal ulcer. A controlled study of habits before first symptoms and before diagnosis. , 1984, Scandinavian journal of gastroenterology.

[8]  D. Wingate.  Gastrointestinal disease: pathophysiology, diagnosis, management , 1984 .

[9]  K. Byth,et al.  Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. , 1985, Gut.

[10]  H. Frankl,et al.  The incidence of duodenal and gastric ulcers in a large health maintenance organization. , 1985, American journal of public health.

[11]  D. Kennedy,et al.  Utilization of nonsteroidal antiinflammatory drugs. , 1985, Arthritis and rheumatism.

[12]  H. Jick,et al.  Certain Nonsteroidal Antiinflammatory Drugs and Hospitalization for Upper Gastrointestinal Bleeding , 1985, Pharmacotherapy.

[13]  J. Pain,et al.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. , 1985, Gut.

[14]  J. Elashoff,et al.  Sex differences in peptic ulcer disease. , 1985, Gastroenterology.

[15]  I. Forgacs,et al.  Outpatient endoscopic survey of smoking and peptic ulcer. , 1986, Gut.

[16]  A J Dobson,et al.  Peptic ulcer and non-steroidal anti-inflammatory agents. , 1986, Gut.

[17]  A. Walker,et al.  Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. , 1987, Archives of internal medicine.

[18]  H. Jick,et al.  NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND HOSPITAL ADMISSION FOR PERFORATED PEPTIC ULCER , 1987, The Lancet.

[19]  A. Blower,et al.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. , 1987, Gut.

[20]  M. Blaser.  Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. , 1987, Gastroenterology.

[21]  C. O'Morain,et al.  CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY , 1987, The Lancet.

[22]  E. Faragher,et al.  Non-Steroidal Anti-Inflammatory Drugs and Peptic Ulceration , 1987, Journal of the Royal College of Physicians of London.

[23]  U Bergman,et al.  Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. , 1988, Journal of clinical epidemiology.

[24]  Endoscopy in peptic diseases and bleeding: a community survey of 1635 patients. , 1988, The New Zealand medical journal.

[25]  C. Dooley,et al.  The clinical significance of Campylobacter pylori. , 1988, Annals of internal medicine.

[26]  Edward L. Lee,et al.  Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin. , 1988, Gastroenterology.

[27]  B. Marshall,et al.  The Campylobacter pylori story. , 1988, Scandinavian journal of gastroenterology. Supplement.

[28]  W. Schaffner,et al.  Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. , 1988, Annals of internal medicine.

[29]  D. Piper,et al.  Smoking, nonsteroidal anti-inflammatory drugs, and acetaminophen in gastric ulcer. A study of associations and of the effects of previous diagnosis on exposure patterns. , 1988, American journal of epidemiology.

[30]  D. Danielson.  Heterogenicity of Campylobacter pylori as demonstrated by Coagglutination testing with rabbit antibodies , 1988 .

[31]  B. Marshall,et al.  PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI , 1988, The Lancet.

[32]  Campylobacter gastritis and associated disorders. , 1988 .

[33]  Peura Da,et al.  Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. , 1989 .

[34]  M. Collins,et al.  Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., Respectively , 1989 .

[35]  J. Elashoff,et al.  A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. , 1989, The New England journal of medicine.

[36]  Schubert Tt,et al.  Prevalence of Campylobacter pylori in patients undergoing upper endoscopy. , 1989 .

[37]  Schubert Tt,et al.  Usefulness of culture, histology, and urease testing in the detection of Campylobacter pylori. , 1989 .

[38]  D. Mellström,et al.  Incidence of peptic ulcer disease in Gothenburg, 1985. , 1989, BMJ.

[39]  S. Zargar,et al.  Prevalence of peptic ulcer in India: an endoscopic and epidemiological study in urban Kashmir. , 1989, Gut.

[40]  K. Shirakawa,et al.  Natural history and epidemiologic studies of peptic ulcer disease in Japan. , 1989, Gastroenterology.

[41]  M. Langman,et al.  Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. , 1989, Gastroenterology.

[42]  J. Mcguigan,et al.  Ulcers, nonsteroidal antiinflammatory drugs, and related matters. , 1989, Gastroenterology.

[43]  J. Reynolds.  Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing. , 1989, Annals of internal medicine.

[44]  A. Buist,et al.  Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. , 1989, Gastroenterology.

[45]  Campylobacter pylori. The organism and its clinical relevance. , 1989, Journal of clinical gastroenterology.

[46]  H. Kaufmann.  Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 4th ed , 1989 .

[47]  A. Buist,et al.  Relative Impact of Smoking and Reduced Pulmonary Function on Peptic Ulcer Risk , 1989 .

[48]  D. Graham,et al.  Campylobacter pylori and peptic ulcer disease. , 1989, Gastroenterology.

[49]  N. Talley,et al.  Helicobacter pylori: controversies and an approach to management. , 1990, Mayo Clinic proceedings.

[50]  J. Kurata,et al.  The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. , 1990, Journal of clinical gastroenterology.

[51]  W. Peterson.  Peptic ulcer--an infectious disease? , 1990, The Western journal of medicine.

[52]  E. Rauws,et al.  Campylobacter pylori and its role in peptic ulcer disease. , 1990, Gastroenterology clinics of North America.

[53]  A. Soll.  Pathogenesis of peptic ulcer and implications for therapy. , 1990, The New England journal of medicine.

[54]  G. Dy.  The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease. , 1990 .

[55]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[56]  W. Ray,et al.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. , 1991, Annals of internal medicine.

[57]  D. Graham,et al.  Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. , 1991, Annals of Internal Medicine.

[58]  P D Klein,et al.  Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal Ulcer , 1992, Annals of Internal Medicine.

[59]  A. Zinsmeister,et al.  Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. , 1992, Gastroenterology.